3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma
NCT ID: NCT03810274
Last Updated: 2019-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2012-02-01
2019-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT
NCT03283293
Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma
NCT02795195
TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients
NCT03588403
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs At Risk
NCT05787522
Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
NCT02113423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3DV+TPS
This experiment included a total of 300 patients with nasopharyngeal carcinoma, using 3DV + TPS software and imported TPS, domestic TPS, these three sets of TPS delineate bilateral crystal, bilateral optic nerve, bilateral eyeball, bilateral parotid gland, oral cavity, spinal cord There are 12 organs in the brainstem and brain, and the accuracy and speed of the 3 sets of TPS sketches are compared.
3DV+TPS;VARIAN TPS;FonicsPlan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3DV+TPS;VARIAN TPS;FonicsPlan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18-70 years old;
3. There is nasopharynx localization enhanced CT, nasopharynx enhanced MRI.
Exclusion Criteria
2. The organs at risk that need to be assessed are invaded by the tumor;
3. Any reason cannot be combined with the research or the researcher believes that it is not suitable for inclusion in this test.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xinqiao Hospital of Chongqing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jianguo Sun
Deputy Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xinqiao Hospital of Chongqing
Chongqing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XQonc-012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.